Casey Woodring Analyst PerformanceAnalyst at JPMorgan Chase & Co.Casey Woodring is a stock analyst at JPMorgan Chase & Co. in the healthcare sector, covering 23 publicly traded companies. Over the past year, Casey Woodring has issued 67 stock ratings, including buy, hold, and sell recommendations. While full access to Casey Woodring's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Casey Woodring's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access to unlock analyst rankings MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings86 Last 1 YearsBuy Recommendations51.81% 43 Buy RatingsCompanies Covered23 Unique Companies Ratings Distribution83RatingsDistribution of strong buy, buy, hold, and sell ratings by Casey Woodring.RatingPercentageCount Strong Buy0.0%0 ratings Buy51.8%43 ratings Hold42.2%35 ratings Sell6.0%5 ratingsOut of 83 total stock ratings issued by Casey Woodring at JPMorgan Chase & Co., the majority (51.8%) have been Buy recommendations, followed by 42.2% Hold and 6.0% Sell.Best & Worst CallsBest Call0000.0%GHSep 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call00.0%ICLRFeb 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ60.9% of companies on NASDAQ14 companiesNYSE39.1% of companies on NYSE9 companiesCasey Woodring, an analyst at JPMorgan Chase & Co., currently covers 23 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageHealthcare23 companies100.0%Casey Woodring of JPMorgan Chase & Co. specializes in stock coverage within the Healthcare sector.Coverage IndustriesIndustryPercentageLIFE SCIENCES TOOLS & SERVICES17 companies73.9%HEALTHCARE PROVIDERS & SERVICES3 companies13.0%HEALTHCARE EQUIPMENT & SUPPLIES2 companies8.7%BIOTECHNOLOGY1 company4.3% Casey Woodring's Ratings History at JPMorgan Chase & Co. Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter More filters Fewer filters Done 0 Results Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsRVTYRevvity11/16/2026Boost Price Target$149.87$165.00Neutral$0.0000.00% ROITXG10x Genomics11/9/2026Lower Price Target$65.22$65.00Neutral$0.0000.00% ROIMTDMettler-Toledo International11/9/2026Boost Price Target$1,763.68$1,725.00Neutral$0.0000.00% ROINTRANatera11/6/2026Lower Price Target$310.67$405.00Overweight$0.0000.00% ROIBLLNBilliontoone11/5/2026Boost Price Target$112.39$135.00Overweight$0.0000.00% ROIWATWaters11/4/2026Boost Price Target$470.58$470.00Neutral$0.0000.00% ROIRVTYRevvity11/4/2026Boost Price Target$162.12$160.00Neutral$0.0000.00% ROISHCSotera Health11/4/2026Lower Price Target$16.40$15.00Underweight$0.0000.00% ROIILMNIllumina10/30/2026Lower Price Target$235.99$300.00Overweight$0.0000.00% ROIIQVIQVIA10/28/2026Boost Price Target$276.48$325.00Overweight$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. DHRDanaher10/22/2026Boost Price Target$234.34$270.00Overweight$0.0000.00% ROIQGENQiagen10/22/2026Downgrade$50.37$52.00Neutral$0.0000.00% ROIIQVIQVIA10/14/2026Boost Price Target$278.47$295.00$0.0000.00% ROIAAgilent Technologies10/14/2026Boost Price Target$172.98$195.00$0.0000.00% ROIWATWaters10/14/2026Boost Price Target$457.93$435.00$0.0000.00% ROISHCSotera Health10/14/2026Downgrade$18.21$17.00Underweight$0.0000.00% ROIBRKRBruker10/14/2026Downgrade$56.19$60.00Neutral$0.0000.00% ROINTRANatera10/14/2026Boost Price Target$394.75$460.00Overweight$0.0000.00% ROICAICaris Life Sciences10/14/2026Boost Price Target$30.26$35.00Overweight$0.0000.00% ROITEMTempus AI10/14/2026Boost Price Target$68.32$70.00Neutral$0.0000.00% ROIQGENQiagen10/14/2026Boost Price Target$45.54$55.00Overweight$0.0000.00% ROIAAgilent Technologies8/27/2026Boost Price Target$156.79$190.00Overweight$0.0000.00% ROIALMRAlamar Biosciences8/11/2026Boost Price Target$33.20$35.00Overweight$0.0000.00% ROINTRANatera8/7/2026Boost Price Target$314.16$360.00Overweight$0.0000.00% ROIQGENQiagen8/7/2026Boost Price Target$42.45$50.00Overweight$0.0000.00% ROISHCSotera Health8/7/2026Boost Price Target$18.89$18.00Neutral$0.0000.00% ROICRLCharles River Laboratories International8/6/2026Upgrade$260.11$310.00Overweight$0.0000.00% ROIBLLNBilliontoone8/6/2026Lower Price Target$91.65$130.00Overweight$0.0000.00% ROIILMNIllumina7/31/2026Boost Price Target$201.13$230.00Overweight$0.0000.00% ROIGHGuardant Health7/31/2026Boost Price Target$160.63$195.00Overweight$0.0000.00% ROIIQVIQVIA7/29/2026Boost Price Target$246.43$285.00Overweight$0.0000.00% ROIRGENRepligen7/29/2026Boost Price Target$142.32$175.00Overweight$0.0000.00% ROIQDELQuidelOrtho7/1/2026Boost Price Target$19.08$12.00Underweight$0.0000.00% ROIICLRIcon6/25/2026Boost Price Target$163.64$155.00Neutral$0.0000.00% ROIILMNIllumina6/10/2026Upgrade$160.03$185.00Overweight$0.0000.00% ROIBRKRBruker6/8/2026Boost Price Target$57.35$65.00Overweight$0.0000.00% ROIICLRIcon5/29/2026Boost Price Target$135.08$130.00Neutral$0.0000.00% ROIICLRIcon5/18/2026Lower Price Target$116.71$120.00Neutral$0.0000.00% ROIALMRAlamar Biosciences5/12/2026Initiated Coverage$23.88$30.00Overweight$0.0000.00% ROITXG10x Genomics5/12/2026Boost Price Target$21.00$20.00Neutral$0.0000.00% ROIThe $40 trillion number nobody won on Tuesday will touch (Ad)Democrats took the House and Senate on election night, but the $40 trillion national debt and the $1 trillion a year in interest on it didn't change. Central banks bought 863 tonnes of gold in 2025 and another 289 tonnes in the second quarter of this year. Gold broke $5,000 and had its best year since 1979 in 2025. Wall Street's biggest bank forecasts gold above $6,000 by early 2027.Get the free Gold Investing Guide and see what central banks knowMTDMettler-Toledo International5/11/2026Lower Price Target$1,087.06$1,200.00Neutral$0.0000.00% ROINTRANatera5/8/2026Boost Price Target$195.54$265.00Overweight$0.0000.00% ROIGHGuardant Health5/8/2026Boost Price Target$92.05$135.00Overweight$0.0000.00% ROICAICaris Life Sciences5/8/2026Lower Price Target$16.08$30.00Overweight$0.0000.00% ROIBLLNBilliontoone5/7/2026Boost Price Target$90.47$125.00Overweight$0.0000.00% ROIRVTYRevvity5/6/2026Lower Price Target$99.50$90.00Neutral$0.0000.00% ROIRGENRepligen5/6/2026Lower Price Target$125.76$165.00Overweight$0.0000.00% ROIWATWaters5/6/2026Boost Price Target$349.91$345.00Neutral$0.0000.00% ROIILMNIllumina5/1/2026Boost Price Target$134.08$125.00Neutral$0.0000.00% ROIQGENQiagen4/29/2026Lower Price Target$33.61$45.00Overweight$0.0000.00% ROICRLCharles River Laboratories International4/13/2026Lower Price Target$178.11$160.00Neutral$0.0000.00% ROIRVTYRevvity3/31/2026Lower Price Target$86.45$96.00Neutral$0.0000.00% ROITEMTempus AI2/25/2026Lower Price Target$53.74$60.00Neutral$0.0000.00% ROIGHGuardant Health2/20/2026Boost Price Target$100.99$130.00Overweight$0.0000.00% ROIQGENQiagen2/6/2026Boost Price Target$51.13$60.00Overweight$0.0000.00% ROIIQVIQVIA2/6/2026Lower Price Target$187.50$225.00Overweight$0.0000.00% ROIILMNIllumina2/6/2026Lower Price Target$119.72$120.00Neutral$0.0000.00% ROITEMTempus AI12/15/2025Lower Price Target$69.96$80.00Neutral$0.0000.00% ROINTRANatera12/15/2025Boost Price Target$229.33$260.00Overweight$0.0000.00% ROIILMNIllumina12/15/2025Boost Price Target$134.71$130.00Neutral$0.0000.00% ROIGHGuardant Health12/15/2025Boost Price Target$103.91$120.00Overweight$0.0000.00% ROICRLCharles River Laboratories International12/15/2025Boost Price Target$197.09$190.00Neutral$0.0000.00% ROIBRKRBruker12/15/2025Boost Price Target$45.61$55.00Overweight$0.0000.00% ROIBLLNBilliontoone12/10/2025Lower Price Target$103.51$145.00Overweight$0.0000.00% ROIBLLNBilliontoone12/1/2025Initiated Coverage$130.18$150.00Overweight$0.0000.00% ROINTRANatera11/25/2025Boost Price Target$238.11$250.00Overweight$0.0000.00% ROIAAgilent Technologies11/25/2025Boost Price Target$155.81$180.00Overweight$0.0000.00% ROITXG10x Genomics11/7/2025Boost Price Target$14.87$15.00Neutral$00.0000.00% ROIQDELQuidelOrtho11/7/2025Lower Price Target$20.32$22.00Underweight$00.0000.00% ROINTRANatera11/7/2025Boost Price Target$199.63$240.00Overweight$000.0000.00% ROICRLCharles River Laboratories International11/6/2025Boost Price Target$170.82$165.00Neutral$000.0000.00% ROISHCSotera Health11/5/2025Boost Price Target$16.14$16.00Neutral$00.0000.00% ROIILMNIllumina10/31/2025Boost Price Target$121.46$105.00Neutral$000.0000.00% ROIIQVIQVIA10/29/2025Boost Price Target$219.81$255.00Overweight$000.0000.00% ROIHOLXHologic10/22/2025Reiterated Rating$73.98$78.00Neutral$0.0000.00% ROIAAgilent Technologies10/9/2025Boost Price Target$140.81$165.00Overweight$000.0000.00% ROIMTDMettler-Toledo International10/9/2025Boost Price Target$1,328.52$1,285.00Neutral$0000.0000.00% ROIWATWaters10/9/2025Boost Price Target$328.36$325.00Neutral$000.0000.00% ROITMOThermo Fisher Scientific10/9/2025Boost Price Target$536.70$650.00Overweight$000.0000.00% ROIGHGuardant Health9/25/2025Boost Price Target$57.67$70.00Overweight$000.0000.00% ROICRLCharles River Laboratories International8/7/2025Boost Price Target$150.12$160.00Neutral$000.0000.00% ROIICLRIcon4/29/2025Downgrade$145.00$150.00Neutral$000.0000.00% ROIQDELQuidelOrtho4/21/2025Lower Price Target$24.35$25.00Underweight$00.0000.00% ROICRLCharles River Laboratories International2/20/2025Lower Price Target$164.90$165.00Neutral$000.0000.00% ROIICLRIcon2/3/2025Lower Price Target$195.96$265.00Overweight$000.0000.00% ROICRLCharles River Laboratories International2/3/2025Lower Price Target$161.46$175.00Neutral$000.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerDeutsche BankBMO Capital Markets Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.